Dean M E, Stock B H
Drug Metab Dispos. 1975 Sep-Oct;3(5):325-31.
A progressive depression in the in vitro hepatic microsomal enzyme metabolism of drug substrates, during pregnancy in the Wistar rat, was measured against various parameters. This depression was greatest with aniline para-hydroxylation and least with p-nitrobenzoic acid reduction. The depressed metabolism, which correlated with prolonged in vivo hexobarbital sleeping times, was paralleled by falls in hepatic microsomal cytochrome P-450 levels. There was a rapid reversal of this depression just before delivery, but these changes did not appear to be controlled by progesterone levels. The suggestion is advanced that the lower levels of hepatic microsomal enzyme activity might reflect a biological control mechanism to ensure the elevated levels of progesterone required to maintain the pregnant state. The relationship between changes in liver weight and enzyme activity was also examined as a possible explanation of the observed depression in drug metabolism during pregnancy.
针对各种参数,对Wistar大鼠孕期体外肝微粒体酶对药物底物的代谢进行了测定,发现其呈进行性降低。苯胺对羟基化的降低最为显著,对硝基苯甲酸还原的降低最不明显。代谢降低与体内己巴比妥睡眠时间延长相关,同时肝微粒体细胞色素P - 450水平也下降。在分娩前这种降低迅速逆转,但这些变化似乎不受孕酮水平控制。有人提出,肝微粒体酶活性较低可能反映了一种生物学控制机制,以确保维持妊娠状态所需的孕酮水平升高。还研究了肝脏重量变化与酶活性之间的关系,以此作为孕期药物代谢降低现象的一种可能解释。